<DOC>
	<DOCNO>NCT00002187</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness two dosage schedule ISIS 2922 treatment advance cytomegalovirus ( CMV ) retinitis</brief_summary>
	<brief_title>A Study ISIS 2922 Treatment Advanced Cytomegalovirus Retinitis</brief_title>
	<detailed_description>This multicenter , prospective , randomize , open-label study compare 2 dosage schedule ISIS 2922 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Fomivirsen</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Oral ganciclovir . Leukocyte growth factor ( GMCSF GCSF ) patient febrile neutropenia . Patients must : Documented AIDS . Clinical diagnosis advance CMV retinitis 1 eye . &gt; = 2 previous induction course antiCMV retinitis therapy license regulatory agency . &gt; 25 % retinal involvement CMV retinitis . Baseline CMV retinitis lesion lead edge &gt; 1000 microgram macula optic disk . Prior Medication : Required : &gt; = 2 previous induction course antiCMV retinitis therapy license regulatory agency . Allowed : All antiCMV therapy ganciclovir must discontinue less 2 day prior entry . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : External ocular infection eye treat . Other herpetic infection retina , toxoplasma , retinochoroiditis , disease fundus would preclude assessment CMV retinitis eye treat . Ocular condition obstruct visualization posterior ocular structure eye treat . Retinal detachment eye treat . Ganciclovir implant eye treat . Known suspected allergy phosphorothioate oligonucleotides intolerance ISIS 2922 . Silicone oil eye treat . Pseudoretinitis pigmentosa . Syphilis . Patients follow prior condition exclude : History surgery correct retinal detachment eye treat . History syphilis . 1 . Systemic antiCMV therapy oral ganciclovir . Mellaril , Stelazine , chlorpromazine clofazimine . Combination use ethambutol fluconazole . Investigational medication and/or procedure treatment CMV retinitis eye treat . Ganciclovir implant delivery device eye treat . Ganciclovir oral . Foscarnet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1998</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>Cytomegalovirus Retinitis</keyword>
	<keyword>fomivirsen</keyword>
	<keyword>Vitreous Body</keyword>
</DOC>